Clinical implications of increased expression of CD40L in patients with acute coronary syndromes.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Chinese Medical Journal

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 12133281
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD40L Activation in Circulating Platelets in Patients with Acute Coronary Syndrome

  2000cited by this paper
• Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.

  1999cited by this paper
• CD40 signaling in vascular cells: a key role in atherosclerosis?

  1998cited by this paper

• Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention

  2021cites this paper
• Inflammation is associated with the presence and severity of chronic coronary syndrome through soluble CD40 ligand.

  2020influential citation
• A SNP in 5′ untranslated region of CD40 gene is associated with an increased risk of ischemic stroke in a Chinese population: a case-control study

  2017cites this paper
• Platelet dependent thrombosis, blood thrombogenicity and response to antiplatelet therapy in health, ageing and type 2 diabetes mellitus

  2016influential citation
• Genetic Variants of CD40 Gene Are Associated with Coronary Artery Disease and Blood Lipid Levels

  2016cites this paper
• Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

  2014cites this paper
• The SNP rs1883832 in CD40 Gene and Risk of Atherosclerosis in Chinese Population: A Meta-Analysis

  2014cites this paper
• Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study.

  2013cites this paper
• Novel Biomarkers Used in the Assessment of Acute Coronary Syndrome

  2013cites this paper
• Biomarkers of Atherosclerosis and Acute Coronary Syndromes - A Clinical Perspective

  2012cites this paper
• β1‐Adrenoceptor antibody‐induced increase in soluble CD40 ligand release in chronic periodontitis patients: role of prostaglandin E2

  2012cites this paper
• Increased expression of monocyte tissue factor and soluble CD40 ligand at mid-term follow-up following percutaneous coronary intervention.

  2011cites this paper
• From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand.

  2010cites this paper
• Association analysis of CD40 gene polymorphism with acute coronary syndrome

  2010cites this paper
• The Relationship between CD40 Gene Polymorphism and Unstable Coronary Atherosclerotic Plaques

  2010cites this paper
• Expression of matrix metalloproteinase-1 mRNA in peripheral blood mononuclear cells of systemic lupus erythematosus patients and its relationship with atherosclerosis.

  2009cites this paper
• Angiogenesis as risk factor for plaque vulnerability.

  2009cites this paper
• Increased concentrations of soluble vascular cell adhesion molecule-1 and soluble CD40L in subjects with metabolic syndrome.

  2009cites this paper
• Monocytes in Acute Coronary Syndromes

  2009cites this paper
• Monocyte Subsets and Their Relevance to Cardiovascular Diseases Series

  2009cites this paper
• Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.

  2009cites this paper
• Linking Inflammation With Atherothrombosis

  2009cites this paper
• The CD40/CD40 ligand system: linking inflammation with atherothrombosis.

  2009cites this paper
• The role of platelets CD40 ligand (CD154) in acute coronary syndromes.

  2009cites this paper
• Relationship between CD40 ligand expression and B type natriuretic peptide levels in patients with chronic heart failure.

  2008cites this paper
• CD 40 soluble ligand and acute coronary syndromes

  2007influential citation
• Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention

  2007cites this paper
• Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes

  2007cites this paper
• Increased expression of CD40 ligand and C-reactive protein in patients with restenosis after percutaneous coronary intervention

  2007cites this paper
• CD 40 SOLUBLE LIGAND CD 40 SOLUBLE LIGAND AND ACUTE CORONARY SYNDROMES AND ACUTE CORONARY SYNDROMES

  2007cites this paper
• The clinical implications of increased coexpression of CD40-CD40 ligand system and C-reactive protein in patients after percutaneous coronary intervention.

  2006cites this paper
• The role of the CD 40 / CD 40 ligand system in the pathogenesis of atherosclerosis

  2006influential citation
• The tumor necrosis factor superfamily in heart failure.

  2006cites this paper
• Rola układu CD40/CD40L w patogenezie procesu miażdżycowego

  2006cites this paper
• The role of CD40/CD40 ligand system in the pathogenesis of atherosclerosis

  2006cites this paper
• Soluble CD40 ligand in acute and chronic heart failure.

  2005cites this paper
• The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.

  2004cites this paper
• Upregulation of CD40--CD40 ligand system in patients with diabetes mellitus.

  2004cites this paper
• Relationship between expression of CD40-CD40 ligand system and serum cholesterol levels in patients with hypercholesterolemia.

  2004cites this paper
• Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.

  2004cites this paper
• SCD40l, PAPP-A und plazentaler-Wachstumsfaktor (PIGF) als biochemische Markerkombinationen bei kardiovaskulären Erkrankungen

  2003cites this paper